MyeChild study2019-03-07T15:10:05+00:00

MyeChild study

This study deepens our research in pharmacogenomics for the treatment of a particular type of leukemia, acute myeloid leukemia, which has a high mortality rate. It consists of an international collaboration, a recruitment in different countries, of DNA samples of patients under 18, who have recently been diagnosed with this disease. The goal is to test a number of therapeutic strategies for various chemotherapeutic agents to improve outcomes through the use of personalized medicine.